← Back to all trials
Not Yet Recruiting
NCT05669638
A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy
Conditions: Immunotherapy, ADR
Sex: All
Ages: 18 Years – N/A
Enrollment: 80
Sponsor: Xuanwu Hospital, Beijing
Location: China
Summary
The goal of this observational study is to learn about in the development process of adverse reactions of anti-PD1 immunotherapy.
The main question it aims to observe:The autoantibody profile of patientsThe adverse reactions of patientsThe changes of immune cells and cytokine in patients
Eligibility Criteria
Inclusion Criteria:Age ≥ 18 years old.Receiving anti-PD1 immunotherapyExclusion Criteria:Vital signs are unstableFunctional impairment of immune system caused by other diseases or other reasons, such as Systemic lupus erythematosus (SLE), AIDS, etc.
Source: ClinicalTrials.gov (NCT05669638). StuddyBuddy aggregates publicly available trial information.
